PGHL

Procter & Gamble Health Ltd.

NSE: PGHL

BSE: 500126

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

5,603.00-64.0 (-1.13%)

8 Sep, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

68.2 / 100

Value Score

37.1 / 100

Price Momentum Score

59.9 / 100

QVM Score

57.3 / 100

Key Metrics

Market Cap

9300.42

P/E (TTM)

26.06

P/B

17.73

P/S (TTM)

6.49

EV/EBITDA

19.60

CAPE (5Y)

37.28

ROE (TTM)

61.59

ROCE (TTM)

80.66

ROA (TTM)

39.98

Avg 3Y ROE

Earnings 3Y CAGR

12.15

Sales 3Y CAGR

5.23

Sales 5Y CAGR

7.27

Debt/Equity

0.02

Consensus TP

7090.00

Strong Buy %

Promoter Holding

51.82

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Procter & Gamble Health Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

High ROE

The company reported strong ROE of 61.59% for 12-month ended 30 Jun 2026

What is ROE (FY)?

High and stable operating margin

The company reported strong operating margin of 30.83% for 12-month ended 30 Jun 2026 and operating margin improved marginally by 46 bps from 1 year ago

What is Operating profit margin?

Low Debt to Equity

The company has low Debt to Equity of 0.02 as on 30 Jun 2026

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 7 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -10.33% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Low EPS growth and in line with median growth of industry

The company delivered low EPS growth of 7.68% for 12-month ended 30 Jun 2026 and the growth was 0.48 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Company's earnings are of low quality

Earnings quality score of 17.5 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

17.5 / 100

Neutral

Stock appears expensive but is at a discount to industry median P/E

PE TTM of 26.06 indicates that the stock is expensive on a standalone basis but discount to industry median P/E is decent at -18.0%

What is P/E Ratio?

Median: 31.78

Value 26.06

-0.96721.13

Moderate revenue growth and in line with median growth of industry

The company delivered moderate revenue growth of 12.57% for 12-month ended 30 Jun 2026 and the growth was 1.98 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 12.57

-99.6111701.8

Moderate dividend yield

The company has a moderate dividend yield of 2.77%

What is Dividend yield?

Financial Snapshot

See detailed analysis

Multi-year trends for Procter & Gamble Health Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Procter & Gamble Health Ltd. Shareholding Pattern

Quarterly breakdown of Procter & Gamble Health Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.85	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82
Indian Promoter	-	-	-	-	-	-	51.82	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign Promoter	51.82	51.82	51.82	51.82	51.82	51.82	-	51.82	51.82	51.82	51.85	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82
Institutions	15.01	15.65	17.23	17.87	18.19	18.26	14.24	14.50	14.48	14.54	18.67	18.76	19.03	19.44	19.69	20.26	19.97	20.94	21.45	21.73	21.08	21.15	21.15	20.81	19.87	18.77
Mutual Funds / UTI	4.21	4.70	6.10	6.34	6.13	6.60	6.91	7.07	6.44	6.61	6.90	7.28	7.34	8.10	8.41	8.98	9.86	10.19	10.45	10.64	10.54	10.65	10.56	10.48	10.20	9.05
FI/Bank/Insurance	6.18	6.19	5.84	5.38	5.34	5.21	1.46	1.46	1.46	1.46	5.66	5.11	4.87	4.08	3.71	3.41	3.55	4.05	4.09	3.77	3.47	3.35	3.14	3.15	3.34	3.23
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	4.62	4.76	5.29	6.15	6.71	6.45	5.88	5.97	6.57	6.47	6.05	6.33	6.72	7.15	7.38	7.60	6.24	6.39	6.61	7.01	6.86	6.99	7.24	6.97	6.20	6.33
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.05	0.10	0.11	0.18	0.27	0.31	0.31	0.30	0.30	0.20	0.15	0.20	0.21	0.13	0.16
Non-Institution	33.17	32.53	30.96	30.31	30.00	29.93	33.94	33.69	33.71	33.64	29.47	29.42	29.15	28.74	28.50	27.92	28.21	27.23	26.74	26.46	27.11	27.03	27.04	27.37	28.31	29.42
Bodies Corporate	2.65	2.69	2.49	2.62	3.15	3.22	3.28	3.28	2.93	2.30	2.19	2.22	2.18	2.19	2.17	2.11	2.05	2.02	1.95	1.76	1.76	1.66	1.76	1.68	1.71	2.39
Others (incl. Retail) No. of shareholders	30.52 44,796	29.84 47,498	28.47 48,617	27.69 49,632	26.85 52,403	26.71 58,111	30.66 62,800	30.41 64,766	30.78 65,503	31.34 64,945	27.28 64,339	27.20 63,056	26.97 60,261	26.55 58,088	26.33 57,168	25.81 55,997	26.16 56,060	25.21 55,231	24.79 54,112	24.70 53,047	25.35 53,289	25.37 51,787	25.28 49,379	25.69 48,683	26.60 50,296	27.03 48,454

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Procter & Gamble Health Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Ishares Core Emerging Markets Mauritius Co	19 Sep 2022	sell	₹ 4,147.50	23.96 k	₹ 9.94 cr
Ishares Core Msci Emerging Markets Etf	19 Sep 2022	buy	₹ 4,147.50	23.96 k	₹ 9.94 cr
Ishares India Sc Mauritius Company	19 Sep 2022	sell	₹ 4,147.50	3.43 k	₹ 1.42 cr
Ishares Msci India Small-Cap Etf	19 Sep 2022	buy	₹ 4,147.50	3.43 k	₹ 1.42 cr

Corporate Actions

History of Procter & Gamble Health Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 45/share
Record date: 27th Aug 2026Ex-date: 27th Aug 2026
Announced on: 26th May 2026
Dividend₹ 110/share
Record date: 12th Feb 2026Ex-date: 12th Feb 2026
Announced on: 6th Feb 2026
Dividend₹ 50/share
Record date: 12th Feb 2026Ex-date: 12th Feb 2026
Announced on: 6th Feb 2026
Dividend₹ 45/share
Record date: 22nd Aug 2025Ex-date: 22nd Aug 2025
Announced on: 29th May 2025
Dividend₹ 80/share
Record date: 21st Feb 2025Ex-date: 21st Feb 2025
Announced on: 31st Jan 2025

Company Profile

Overview of Procter & Gamble Health Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of...

Key personnel

Ms. Zeal Bhavin Rupani

Compliance Officer, Company Secretary

Mr. Subramanian MadhavanD

Non-Executive Independent Chairman of the Board

Mr. Shashank SrowthyD

Chief Financial Officer, Additional Executive Director

Mr. Milind ThatteD

Managing Director, Executive Director

Mr. Aalok AgrawalD

Non-Executive Director

Ms. Seema SambasivanD

Non-Executive Director

Ms. Krishna SarmaD

Non-Executive Independent Director

Mr. Sharad TyagiD

Non-Executive Independent Director

View all

Incorporated on

26 Apr 1967

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

1,276

IPO date

21 Nov 1993

Free Float

79,36,872

Website

https://www.pghealthindia.com/

Phone no.

+912262109000

Address

P & G Plaza, Cardinal Gracias Road Chakala, Andheri East, Mumbai City, MUMBAI, 400099, India

Frequently Asked Questions

What is the current share price of Procter & Gamble Health Ltd.?

The current share price of Procter & Gamble Health Ltd. is ₹ 5,603.00 as of 8 Sep 2026.

What is the market capitalisation of Procter & Gamble Health Ltd.?

The market capitalisation of Procter & Gamble Health Ltd. stands at ₹ 9,300.42 Cr.

What is the PE ratio of Procter & Gamble Health Ltd.?

The Price-to-Earnings (PE) ratio of Procter & Gamble Health Ltd. is 26.06 as of the latest trailing twelve months data.

What is the ROE and ROCE of Procter & Gamble Health Ltd.?

Procter & Gamble Health Ltd. has a Return on Equity (ROE) of 61.59% and a Return on Capital Employed (ROCE) of 80.66% as per the latest financial reports.

What is the 52-week high and low of Procter & Gamble Health Ltd.?

The 52-week high of Procter & Gamble Health Ltd. is - and the 52-week low is -.

What is the dividend yield of Procter & Gamble Health Ltd.?

The dividend yield of Procter & Gamble Health Ltd. is 2.77% based on the current market price.

What is the FII and DII holding in Procter & Gamble Health Ltd.?

Foreign Institutional Investors (FII) hold 6.33%, Domestic Institutional Investors (DII) hold 12.28% and retail/public investors hold 27.03% of Procter & Gamble Health Ltd. shares.

What sector does Procter & Gamble Health Ltd. belong to?

Procter & Gamble Health Ltd. operates in the Healthcare sector.

What is the beta of Procter & Gamble Health Ltd.?

The beta of Procter & Gamble Health Ltd. is 0.45, indicating its price volatility relative to the broader market. Over the past 1 year, Procter & Gamble Health Ltd. has delivered an absolute return of -11.44%.

What is the RSI of Procter & Gamble Health Ltd.?

The 14-day Relative Strength Index (RSI) of Procter & Gamble Health Ltd. is 32.68, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Procter & Gamble Health Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Procter & Gamble Health Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile